Side-by-side comparison of AI visibility scores, market position, and capabilities
Diversified industrial manufacturer with $15.9B FY2024 revenue; 80/20 business model drives 25%+ operating margins; 50+ year dividend growth streak; new CEO Chris O'Herlihy 2024.
Illinois Tool Works (ITW) is a diversified manufacturer of highly engineered industrial components, tools, and equipment, founded in 1912 in Chicago, Illinois where it remains headquartered, trading on NYSE (ITW). The company generated approximately $15.9 billion in revenues for FY2024 under CEO Christopher O'Herlihy, who succeeded longtime CEO E. Scott Santi in 2024 and continues the long-tenured management team's disciplined execution of ITW's 80/20 business model. ITW operates seven diversified segments: Automotive OEM (components for cars and trucks), Food Equipment (professional kitchen equipment and service), Test & Measurement and Electronics, Welding (Miller welders and equipment), Polymers & Fluids (adhesives, lubricants, sealants), Construction Products (anchors, fasteners, fire protection), and Specialty Products (diversified industrial niche products).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.